• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES SAPIEN 3 ULTRA SYSTEM; PROSTHESIS, MITRAL VALVE, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES SAPIEN 3 ULTRA SYSTEM; PROSTHESIS, MITRAL VALVE, PERCUTANEOUSLY DELIVERED Back to Search Results
Catalog Number 147739
Device Problems Entrapment of Device (1212); Malposition of Device (2616); Activation Failure (3270)
Patient Problem Valvular Insufficiency/ Regurgitation (4449)
Event Date 01/06/2021
Event Type  Injury  
Event Description
Patient presented for an elective transfemoral aortic valve replacement (tavr).Past medical history includes severe aortic stenosis and right common and external iliac artery stenting.Access was initiated in the right femoral artery under ultrasound and angiography.The valve was positioned and deployed, however the ventricular side of the valve did not dilate appropriately.The partially deployed valve was pulled distally beyond the aortic valve and into the aorta.It was then determined the right iliac stent was found on the ventricular end of the tavr valve, restricting from deployment.The tavr and iliac stent were pulled back beyond the arch vessels in the transverse to descending aorta as the valve balloon would not come off of the stent.A successful attempt followed in dislodging the tavr balloon from the valve.Attempts to then fracture the stent were unsuccessful.Attempts to snare and separate the stent from the valve were not successful.The procedure was then concluded.Surgical intervention for removal of the valve and stent is required.A second tavr procedure was performed successfully 5 days later.Further intervention for retained valve/stent is under evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SAPIEN 3 ULTRA SYSTEM
Type of Device
PROSTHESIS, MITRAL VALVE, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
MDR Report Key11243159
MDR Text Key229118438
Report Number11243159
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source User Facility
Reporter Occupation Nurse
Type of Report Initial
Report Date 01/12/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/28/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number147739
Device Lot Number7566839
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/12/2021
Event Location Hospital
Date Report to Manufacturer01/28/2021
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age30660 DA
-
-